The association between coronary slow flow and platelet distribution width among patients with stable angina pectoris

Basit Öğe Kaydı
dc.contributor.authorOzyurtlu, Ferhat
dc.contributor.authorYavuz, Veysel
dc.contributor.authorCetin, Nurullah
dc.contributor.authorAcet, Halit
dc.contributor.authorAyhan, Erkan
dc.contributor.authorIsik, Turgay
dc.date.accessioned2024-04-24T17:24:55Z
dc.date.available2024-04-24T17:24:55Z
dc.date.issued2014
dc.departmentDicle Üniversitesien_US
dc.description.abstractIntroduction: Coronary slow flow (CSF) is an angiographic phenomenon characterised by the delay of distal vessel opacification in the absence of significant stenosis of the epicardial coronary arteries. Some of the factors playing a role in CSF pathophysiology are increased thrombogenic activity and inflammation. Aim: To examine the relationship between platelet distribution width (PDW) and CSF. Material and methods: Taking into consideration the exclusion criteria, 136 patients with CSF and 152 patients with normal coronary angiographies (control group) were included in the study. The association between thrombolysis infarction frame count (TFC) in myocardial and laboratory and other clinical parameters were evaluated. Results: The stated parameters were significantly higher in the group with CSF than in the normal coronary angiography group (control group). The PDW (16.6 +/- 0.7 vs. 16.4 +/- 0.6, p = 0.002), neutrophil lymphocyte ratio (NLR) (3.1 +/- 3.4 vs. 2.4 +/- 1.1, p = 0.027), haemoglobin (Hb) (14.1 +/- 1.3 vs. 14.7 +/- 1.1, p < 0.001), and red cell distribution width (Row) (13.6 +/- 0.7 vs. 14.1 +/- 2.8, p = 0.026) were significantly higher in the CSF group than in the control group. Moreover, our study showed that PDW > 16.15 and Hb > 13.75 were predictors of the presence of CSF with sensitivities of 83% and 73% and specificities of 40% and 42%, respectively. Conclusions: This study has demonstrated that compared to normal coronary flow, PDW, Hb, NLR, and RDW are significantly higher in CSF patients. We believe that further studies are needed to clarify the role of PDW and Hb in patients with CSF.en_US
dc.identifier.doi10.5114/pwki.2014.45142
dc.identifier.endpage165en_US
dc.identifier.issn1734-9338
dc.identifier.issn1897-4295
dc.identifier.issue3en_US
dc.identifier.pmid25489301
dc.identifier.scopus2-s2.0-84907291000
dc.identifier.scopusqualityQ3
dc.identifier.startpage161en_US
dc.identifier.urihttps://doi.org/10.5114/pwki.2014.45142
dc.identifier.urihttps://hdl.handle.net/11468/19876
dc.identifier.volume10en_US
dc.identifier.wosWOS:000343273500005
dc.identifier.wosqualityQ4
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoenen_US
dc.publisherTermedia Publishing House Ltden_US
dc.relation.ispartofPostepy W Kardiologii Interwencyjnej
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectCoronary Slow Flowen_US
dc.subjectPlatelet Distribution Widthen_US
dc.titleThe association between coronary slow flow and platelet distribution width among patients with stable angina pectorisen_US
dc.titleThe association between coronary slow flow and platelet distribution width among patients with stable angina pectoris
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu